SynthesisMolecular biotechnology2026

CRISPR/Cas9 System as a Promising Therapy in Thalassemia and Sickle Cell Disease: A Systematic Review of Clinical Trials.

Rehab Ahmed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.